Ozempic manufacturer Novo Nordisk said patient safety is a priority and “the benefit-risk profile of semaglutide remains ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been ...

Food companies fatten us up only for Big Pharma to let us inject ourselves slim again. Crazy? Perhaps it’s the beginning of ...

For many people, the holidays mean large family dinners with filling sides, sweet treats, and festive drinks — all things for ...

That's why Novo Nordisk's shares are worth sticking with for good, and at about $108 apiece, investors can afford two of them ...

Eli Lilly just gave investors several reasons to cheer.

Nestle is launching protein shots in the United States which it says help suppress appetite for people looking to shed pounds ...

Hims sells a compounded version of Novo Nordisk's (NVO) semaglutide, the active ingredient in Wegovy and Ozempic for, ...

Merck gets exclusive global rights to develop, manufacture and commercialize GLP-1 receptor agonist, HS-10535, from Hansoh ...

The agency, which oversees Medicare plans for people aged 65 and older or with disabilities, said healthcare spending ...

Blockbuster weight-loss drugs can help to stop and reverse the global obesity crisis, experts from the World Health ...